DYNE THERAPEUTICS

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.

DYNE THERAPEUTICS

Social Links:

Twitter

Industry:

Biotechnology Health Care Medical Pharmaceutical

Founded:

2018-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.dyne-tx.com

Total Employee:

11+

Status:

Active

Total Funding:

333 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network

Similar Organizations

ribonexus-logo

Ribonexus

Ribonexus is a biotech specialized in the development of new therapies to combat cancer disease.

capital-rx-logo

Capital Rx

Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.

cisiv-logo

Cisiv

Cisiv is a developer of technology solutions for pharmaceutical companies.

endeavor-biomedicines-logo

Endeavor BioMedicines

Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.

haya-therapeutics-logo

HAYA Therapeutics

HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.

luca-science-logo

LUCA Science

LUCA Science develops innovative treatments intended for mitochondrial and related diseases.

neuron23-logo

Neuron23

Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.

orasis-pharmaceuticals-logo

Orasis Pharmaceuticals

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.

polyactiva-logo

PolyActiva

PolyActiva develops products that enable drug release from medical devices.

priothera-logo

Priothera

Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.

pyxis-oncology-logo

Pyxis Oncology

Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.

sydnexis-logo

Sydnexis

Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.

syndesi-therapeutics-logo

Syndesi Therapeutics

Syndesi Therapeutics develops a drug candidate for the treatment of consecutive cognitive disorders of various neurological conditions.

Current Advisors List

sudhir-agrawal_image

Sudhir Agrawal Member, Scientific Advisory Board @ Dyne Therapeutics
Advisor
2018-06-01

Current Employees Featured

romesh-subramanian_image

Romesh Subramanian
Romesh Subramanian CEO and Founder @ Dyne Therapeutics
CEO and Founder
2018-01-01

molly-white_image

Molly White
Molly White Vice President, Medical Communications & Advocacy @ Dyne Therapeutics
Vice President, Medical Communications & Advocacy
2020-01-01

wildon-farwell_image